Logo image of VSTE

VAST RENEWABLES LIMITED (VSTE) Stock Fundamental Analysis

NASDAQ:VSTE - Nasdaq - AU0000288284 - Common Stock - Currency: USD

0.3816  +0.01 (+1.49%)

After market: 0.3734 -0.01 (-2.15%)

Fundamental Rating

1

Overall VSTE gets a fundamental rating of 1 out of 10. We evaluated VSTE against 97 industry peers in the Electrical Equipment industry. VSTE has a bad profitability rating. Also its financial health evaluation is rather negative. VSTE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year VSTE has reported negative net income.
In the past year VSTE has reported a negative cash flow from operations.
VSTE had negative earnings in 4 of the past 5 years.
VSTE had negative operating cash flow in 4 of the past 5 years.
VSTE Yearly Net Income VS EBIT VS OCF VS FCFVSTE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M -250M

1.2 Ratios

VSTE has a Return On Assets of -2395.08%. This is amonst the worse of the industry: VSTE underperforms 96.91% of its industry peers.
Industry RankSector Rank
ROA -2395.08%
ROE N/A
ROIC N/A
ROA(3y)-620.14%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VSTE Yearly ROA, ROE, ROICVSTE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 1K -1K 2K 3K

1.3 Margins

VSTE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VSTE Yearly Profit, Operating, Gross MarginsVSTE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -20K -40K -60K -80K

2

2. Health

2.1 Basic Checks

VSTE does not have a ROIC to compare to the WACC, probably because it is not profitable.
VSTE has less shares outstanding than it did 1 year ago.
The debt/assets ratio for VSTE is higher compared to a year ago.
VSTE Yearly Shares OutstandingVSTE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
VSTE Yearly Total Debt VS Total AssetsVSTE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -69.46, we must say that VSTE is in the distress zone and has some risk of bankruptcy.
VSTE has a worse Altman-Z score (-69.46) than 95.88% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -69.46
ROIC/WACCN/A
WACC7.19%
VSTE Yearly LT Debt VS Equity VS FCFVSTE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

VSTE has a Current Ratio of 1.11. This is a normal value and indicates that VSTE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.11, VSTE is doing worse than 74.23% of the companies in the same industry.
A Quick Ratio of 1.03 indicates that VSTE should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.03, VSTE is in line with its industry, outperforming 45.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.03
VSTE Yearly Current Assets VS Current LiabilitesVSTE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

0

3. Growth

3.1 Past

The earnings per share for VSTE have decreased strongly by -31157.18% in the last year.
EPS 1Y (TTM)-31157.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.04%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VSTE Yearly Revenue VS EstimatesVSTE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 100K 200K 300K

0

4. Valuation

4.1 Price/Earnings Ratio

VSTE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VSTE Price Earnings VS Forward Price EarningsVSTE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VSTE Per share dataVSTE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

VSTE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VAST RENEWABLES LIMITED

NASDAQ:VSTE (4/25/2025, 8:00:01 PM)

After market: 0.3734 -0.01 (-2.15%)

0.3816

+0.01 (+1.49%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.3%
Inst Owner Change0%
Ins Owners4.82%
Ins Owner ChangeN/A
Market Cap11.44M
AnalystsN/A
Price TargetN/A
Short Float %5.71%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 33.44
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-11.68
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.54
OCFYN/A
SpS0.01
BVpS-0.13
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2395.08%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-620.14%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 116.92%
Cap/Sales 44.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 1.03
Altman-Z -69.46
F-Score2
WACC7.19%
ROIC/WACCN/A
Cap/Depr(3y)78.72%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31157.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6336.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1347.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1343.47%
OCF growth 3YN/A
OCF growth 5YN/A